Vortioxetine for Post-COVID-19 Condition
Clinical trial NCT05047952 · COMPLETED
Trial details
- NCT number
- NCT05047952
- Sponsor
- Brain and Cognition Discovery Foundation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-16
- Primary completion
- 2023-02-22
- Enrollment
- 149
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.